TPF方案诱导化疗鼻咽癌后Ⅲ~Ⅳ度骨髓抑制的临床分析
作者简介:

文忠,Email: wenzhong60@163.com

基金项目:

广东省自然科学基金(S2011010003947)。


Clinical analysis of grade Ⅲ~Ⅳ myelosuppression after induction chemotherapy with docetaxel, cisplatin and 5fluorouracil (TPF) in nasopharyngeal carcinoma
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
    摘要:

    目的观察和分析顺铂联合多西他赛和氟尿嘧啶(TPF方案)在鼻咽部鳞状细胞癌的诱导化疗中出现Ⅲ~Ⅳ度骨髓抑制的临床特征和治疗策略。方法收集南方医科大学珠江医院接受TPF方案诱导化疗的186例首诊鼻咽癌患者临床资料,回顾性分析患者出现Ⅲ~Ⅳ度骨髓抑制情况及其波动规律,以期早期发现和治疗化疗后骨髓抑制。结果本组患者中有31例出现骨髓抑制,白细胞出现Ⅲ~Ⅳ度抑制时间为化疗后6~13 d,平均时间8.7 d;中性粒细胞抑制波动规律与白细胞相似,均呈“U”形波动,但出现时间要迟1~2 d,时间为化疗后7~14 d,平均时间10 d。结论TPF方案诱导化疗鼻咽癌出现骨髓抑制主要表现为白细胞减少伴随中性粒细胞下降,其波动规律呈“U”形改变;根据波动规律早期监测并治疗化疗后的骨髓抑制,及时予以升白细胞治疗可避免感染及严重毒副反应的发生,使鼻咽癌患者顺利进行TPF诱导化学治疗并如期行根治性放射治疗。

    Abstract:

    ObjectiveTo observe and analyze the clinical features and treatment strategies of grade Ⅲ~Ⅳ myelosuppression after induction chemotherapy with docetaxel, cisplatin and 5fluorouracil (TPF) in nasopharyngeal carcinoma (NPC).MethodsA total of 186 initiallydiagnosed NPC patients received TPF induction chemotherapy in our hospital from 2016 to 2019 were collected. Grade Ⅲ~Ⅳ myelosuppression and its variation rule was analyzed retrospectively for early detection and treatment of myelosuppression after chemotherapy.ResultsOf all the 186 patients, myelosuppression occurred in 31. Leukocyte suppression of grade Ⅲ~Ⅳappeared in 6 to 13 d after chemotherapy with an average of 8.7. The neutrophil suppression occurred 1 to 2 d later, in 7 to 14 d after chemotherapy with an average of 10, and fluctuated in “U” shape which was similar to that of leukocyte.ConclusionThe myelosuppression of TPF induction chemotherapy is manifested as leukopenia accompanied by neutropenia with a “U”shaped fluctuation pattern. Early detection and treatment of myelosuppression according to the fluctuation rule can avoid infection and serious side effects, therefore facilitate successful performance of TPF induction chemotherapy and radical radiotherapy in NPC patients.

    参考文献
    相似文献
    引证文献
引用本文

蔡智谋,徐铭鸿,文忠. TPF方案诱导化疗鼻咽癌后Ⅲ~Ⅳ度骨髓抑制的临床分析[J].中国耳鼻咽喉颅底外科杂志,2020,26(3):312-317

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 在线发布日期: 2020-05-19
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭